- Home
- EQ vs SRG Comparison
EQ vs SRG Comparison
Compare EQ & SRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EQ | SRG |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.4M | 102.5M |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | EQ | SRG |
|---|---|---|
| Price | $1.24 | $1.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $8.56 | N/A |
| AVG Volume (30 Days) | ★ 543.3K | 135.0K |
| Earning Date | 11-12-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.90 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $41,095,000.00 | $18,204,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 3.30 |
| 52 Week Low | $1.19 | $1.55 |
| 52 Week High | $6.20 | $4.38 |
Technical Indicators
Market Signals| Indicator | EQ | SRG |
|---|---|---|
| Relative Strength Index (RSI) | 25.58 | 34.21 |
| Support Level | N/A | $1.57 |
| Resistance Level | $1.51 | $2.08 |
| Average True Range (ATR) | 0.11 | 0.08 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 0.00 | 14.52 |
Price Performance
Historical ComparisonAbout EQ Equillium Inc.
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
About SRG Seritage Growth Properties
Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management, sale, and leasing of diversified retail and mixed-use properties throughout the United States.